CCT251236
CCT251236 is an orally available pirin ligand from a heat shock transcription factor 1 (hsf1) phenotypic screen with an IC50 of 19 nM for inhibition of HSF1-mediated HSP72 induction.
Product Specifications
CAS Number
1693731-40-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CCT251236.html
Purity
98.82
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC=C(NC(C2=CC(OCCO3)=C3C=C2)=O)C=C1NC(C4=CC(C=CC(OCCN5CCCC5)=N6)=C6C=C4)=O
Molecular Formula
C32H32N4O5
Molecular Weight
552.62
Precautions
H302, H315, H319, H335
References & Citations
[1]Cheeseman MD, et al. Discovery of a Chemical Probe Bisamide (CCT251236) : An OrallyBioavailable Efficacious Pirin Ligand from a Heat ShockTranscription Factor 1 (HSF1) Phenotypic Screen. J Med Chem. 2017 Jan 12;60 (1) :180-201.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HSP70
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940035-100 1x 100 µL
Calgranulin B / MRP-8/-14 / MAC 387 / S100A8/A9 / Macrophage Ag (MAC387), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042655-100 1x 100 µL
MMP3 (Marker of Metastasis and Rheumatoid Arthritis) (MMP3/2655), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC043786-100 1x 100 µL
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (rAKT1/2491), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details